Immune-mediated Kidney Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-06
Clinical Trial Update: An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Refractory Immune-mediated Kidney Disease [EARLY_Phase 1]
An early-phase 1 exploratory study is evaluating the safety and efficacy of anti-CD19/BCMA U CAR-T cells for relapsed/refractory immune-medi…